Effectiveness of alpine climate treatment for children with difficult to treat atopic dermatitis: Results of a pragmatic randomized controlled trial (DAVOS trial)
Clinical & Experimental Allergy2017Vol. 48(2), pp. 186–195
Citations Over TimeTop 10% of 2017 papers
Karin B. Fieten, Renske Schappin, Wieneke T. Zijlstra, L. Figee, Jaap J. Beutler, F. Raymakers, Harmieke van Os‐Medendorp, Rebecca K. Stellato, M. Vandewall, J. Winkelhof, Monica Uniken Venema, Carla A.F.M. Bruijnzeel-Koomen, Lucia H. Rijssenbeek‐Nouwens, Cornelis K. van der Ent, Els van Hoffen, Y. Meijer, Suzanne G.M.A. Pasmans
Abstract
For children with difficult to treat AD, there was no additional long-term benefit of alpine climate treatment, in contrast to the short-term, compared to an outpatient treatment programme in moderate maritime climate, using a personalized integrative multidisciplinary treatment approach.
Related Papers
- → Atopic dermatitis phenotypes and the need for personalized medicine(2017)154 cited
- → New Directions in Understanding Atopic March Starting from Atopic Dermatitis(2022)42 cited
- → Allergic march in children: Atopic dermatitis in Japanese children with bronchial asthma(1996)5 cited
- Expression and significance of interleukin 4 in patients with atopic dermatitis(2009)
- → A Systemic Review of Dupilumab Efficacy and Safety by Phenotypic Variations of Atopic Dermatitis(2021)